6 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2262685/biotech-stock-roundup-biib-bmy-s-q1-earnings-incy-s-acquisition-updates-from-vrtx?cid=CS-ZC-FT-analyst_blog|earnings_article-2262685
Apr 25, 2024 - Biogen (BIIB) and Bristol Myers (BMY) are in focus following Q1 earnings announcement.
zc:8506602132430980156
0
https://www.zacks.com/stock/news/2253912/novartis-nvs-to-undertake-job-cuts-in-development-department?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253912
Apr 11, 2024 - Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
zc:-5842438182433512160
0
https://www.zacks.com/stock/news/2252827/agilent-a-is-set-for-analytica-2024-with-advanced-products?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2252827
Apr 09, 2024 - Agilent (A) plans to showcase its new products for analytical laboratories at Analytica 2024, boosting its overall product portfolio.
zc:8904178564272510078
0
https://www.zacks.com/stock/news/2225655/incyte-s-incy-q4-earnings-revenues-fall-shy-of-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2225655
Feb 13, 2024 - Incyte's (INCY) fourth-quarter 2023 earnings and revenues miss estimates. Quarterly revenues cross the $1 billion mark for the first time on the continued growth of Jakafi and the strong launch of Opzelura.
zc:8919350061650660899
0
https://www.zacks.com/stock/news/2225440/here-s-what-key-metrics-tell-us-about-incyte-incy-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2225440
Feb 13, 2024 - The headline numbers for Incyte (INCY) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:2254810786304545348
0
https://www.zacks.com/stock/news/2224024/ahead-of-incyte-incy-q4-earnings-get-ready-with-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224024
Feb 09, 2024 - Evaluate the expected performance of Incyte (INCY) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
zc:-2384213918245316093
0